A recent study assessed the US real-world trends in prescription analgesic use among Medicare patients with CKD, analyzing the potential relationships between analgesics and patient outcomes. Use of ...
—Patients with CKD are advised against using opioids and NSAIDs for long-term pain. These authors attempted to address conflicting data in this area. Reviewed by Clifton M. Jackness, MD, Adjunct ...
Mild analgesics (hereafter, analgesics) consisting of paracetamol and NSAIDs are among the most used pharmaceutical drugs worldwide as well as the most released into the environment Epidemiological ...
Many trials found no clear differences between various nonaspirin, nonselective NSAIDs or partially selective NSAIDs (meloxicam, nabumetone, etodolac) in efficacy for pain relief or improvement in ...
Tylenol and NSAIDs both help with pain perception and fever, but the medications do have one key difference. Distinctly, ...
Existing literature examining analgesic medication use and epithelial ovarian cancer (EOC) risk has been inconsistent, with the majority of studies reporting an inverse association. Race-specific ...
Certain analgesics have been associated with an increased risk for renal cell carcinoma (RCC), particularly among patients who use the medications for longer durations. Excluding aspirin, the relative ...
Cost comparison of robotic, laparoscopic, and open partial nephrectomy. Background: Analgesics have been linked to an increased risk of developing renal cell carcinoma (RCC), but the evidence is mixed ...
Boston, MA - Amid a flurry of concern over selective COX-2 inhibitors, many doctors have been switching patients to traditional nonsteroidal anti-inflammatory drugs (NSAIDs). But a new large ...
Researchers have determined that regular use of aspirin, acetaminophen and non-steroidal anti-inflammatory drugs increases the risk of hearing loss in men, particularly in younger men, below age 60.
In a recent study posted to the medRxiv* preprint server, University of Arizona researchers assessed the relationship between antibody responses and analgesic usage after coronavirus disease 2019 ...
Dublin, May 17, 2022 (GLOBE NEWSWIRE) -- The "Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)" report has been added to ...